COVID-associated rhinocerebral mucormycosis: a retrospective analysis of presentation and outcomes.
Eur Arch Otorhinolaryngol
; 2022 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: covidwho-2321394
ABSTRACT
OBJECTIVES:
To comprehensively analyse the disease presentation and mortality of COVID-associated rhino-orbito-cerebral mucormycosis.METHODS:
A retrospective analysis of the demographics, clinical and radiographic findings was performed. A binary logistic regression analysis was performed to examine the survival of patients with mucormycosis from hypothesised predictors.RESULTS:
A total of 202 patients were included in this study. Statistical significance was demonstrated in the predilection to the male gender, recent history of SARS-COV-2, history of use of corticosteroid and hyperglycemia in this cohort of CAM. The mortality rate was 18.31%. Advanced age, raised HbA1c and intra-orbital extension were found to be predictors adversely affecting survival.CONCLUSION:
Early diagnosis, aggressive surgical therapy, early and appropriate medical therapy can help improve outcomes. LEVEL OF EVIDENCE Level 4.
Texto completo:
Disponível
Coleções:
Bases de dados internacionais
Base de dados:
MEDLINE
Tipo de estudo:
Estudo de coorte
/
Estudo observacional
/
Estudo prognóstico
Idioma:
Inglês
Assunto da revista:
Otorrinolaringologia
Ano de publicação:
2022
Tipo de documento:
Artigo
País de afiliação:
S00405-022-07544-y
Similares
MEDLINE
...
LILACS
LIS